← Evidence map

ReviewFrontiers in oncology2015

Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical Data.

Patrick A Ott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

134 papers cite itlatest 60 shown

2015
…
2017
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 26442214